Assoc. Prof. Sude Hatun AKTIMUR

Assoc. Prof. Sude Hatun AKTIMUR

Internal Medicine, Department of Internal Medicine, Samsun University Faculty of Medicine

Education: 2006, Gazi University Faculty of Medicine – 2011, Ankara Atatürk Training and Research Hospital, Internal Medicine Specialist – 2017, Samsun Ondokuz Mayıs University Faculty of Medicine, Hematology Minor Specialist

Research Areas: Current treatment approaches and agents in hematological malignancies, effects of hematological parameters on malignancy and other diseases, treatment and chemotherapy applications of all kinds of hematological malignancies and diseases, benign hematological diseases, benefits of immune plasma applications in COVID-19 epidemic, COVID-19 infected patients The effects of blood groups on disease spread and outcomes in patients are concerned with anticoagulation in COVID-19 infection.

Selected Studies: He wrote his specialty thesis in medicine titled “Effects of Probiotics, Prebiotics and Symbiotics on Serum Cholesterol Levels” (2011). “Safety and Efficacy of Ankaferd Hemostat (ABS) in the Chemotherapy-Induced Oral Mucositis” (2015), “Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML” (2015), “Neutrophil-to-lymphocyte ratio as a diagnostic biomarker for the diagnosis of acute mesenteric ischemia” (2016), “The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases” (2016), “The evaluation of ENA-78 and fibrinogen levels for the differential diagnosis of familial Mediterranean fever and acute appendicitis” (2019), “The Assessment of the Relationship Between ABO Blood Groups and Covid-19 Infection” (2020)

Office: Samsun Health Application and Research Center (Samsun Training and Research Hospital)

e-mail: [email protected]

Tel: +90 (362) 311 15 00

Google Academic YÖKAKADEMIC

Öğrenci Destek Hattı